<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Natural killer (NK) cell-mediated cytotoxicity contributes to the innate immune response against numerous <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0006721'>Acute lymphoblastic leukemias</z:hpo> (ALL) often display a high degree of resistance, the mechanisms of which have not been elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We used the well-characterized NK cell line NK-92 as a model to investigate whether mechanisms commonly implicated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> escape from NK cell killing are relevant for ALL </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We demonstrate selective resistance of B-precursor ALL to NK-92 cytotoxicity even in the absence of inhibitory killer cell immunoglobulin-like receptors (KIR), except for KIR2DL4 </plain></SENT>
<SENT sid="4" pm="."><plain>We also show that human leukocyte antigen-G, a ligand of KIR2DL4, expressed on a subset of ALL, does not mediate resistance of NK-cell mediated lysis </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, intracellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule/lymphocyte function-associated antigen-1 interaction did not contribute significantly to resistance </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast the NK-sensitive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> (MOLT-4) expressed moderate amounts of MHC class I chain-related gene AB (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B) a ligand for the NK cell activating receptor NKG2D, while expression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>/B was absent in resistant <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The NK cell-resistance of B-lineage ALLs does not appear to involve inhibitory mechanisms, but suggests deficient NK cell activation </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, immunostrategies designed to enhance ALL sensitivity toward NK cell-mediated cytotoxicity should focus on mechanisms of NK cell activation </plain></SENT>
</text></document>